Daehwajeayak Acquires Patent Rights for Syrup and Powder Formulation Technologies
[Asia Economy Reporter Ji Yeon-jin] Daehwa Pharmaceutical announced on the 4th that it has obtained a patent for an oral pharmaceutical composition in the form of a syrup or powder formulation containing water-soluble active pharmaceutical ingredients.
Hot Picks Today
!["Three Years' Worth of Public Pensions Lost: NPS Faces 180 Trillion Won Shock After Missing Peak Selloff [In-Depth Analysis of Funds and Mutual Aid Associations]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026073116453666020_1785483936.png)
"Three Years' Worth of Public Pensions Lost: NPS Faces 180 Trillion Won Shock After Missing Peak Selloff [In-Depth Analysis of Funds and Mutual Aid Associations]"
- "Record Profits" as Strait of Hormuz Shuts Down... The Unexpected Company Benefiting from the War Boom
- Jang Donghyuk Warns: "If President Lee Rejects Veto, Abolition of Supplementary Investigation Authority Will Lead to Administration's End"
- "Who Shows Up Like That to a Wedding?" Outrage Grows in the US Over Fashion Revealing Underwear
- [Report] Parched Reservoirs, Collapsed Cattle... ‘43-Degree’ Inferno Strikes Yangsan
This patent relates to a technology that formulates zanamivir inhalation into a syrup form to increase ease of administration, combining the advantages of syrup form with the convenience of storage and distribution while preventing moisture changes in the powder formulation.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
